Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine

NATICK, Mass., Feb. 15, 2011 /PRNewswire/ — Boston Scientific
Corporation (NYSE:
BSX) today announced that it has established a $1.7 million
endowment to fund the “Donald S. Baim, M.D., ’75 Scholarship Fund”
for Yale School of Medicine.  This scholarship fund will honor
the late interventional cardiology pioneer and Yale School of
Medicine graduate who served as Boston Scientific’s Chief Medical
and Scientific Officer from 2006 until 2009, when he died
unexpectedly.

At Boston Scientific, Dr. Baim provided oversight to preclinical
and clinical studies, educational programs and physician
relationships.  He was a key contributor to the Company’s
technology development strategy, including the assessment of
strategic acquisitions and partnering opportunities, while also
serving as the Company’s leading patient advocate for new products
and procedures.  Under Dr. Baim’s leadership, Boston
Scientific’s Clinical Sciences group was strengthened considerably,
increasing its emphasis on leading clinical research to support
evidence-based medicine.

“Dr. Baim was a pioneer in interventional cardiology and
less-invasive medicine who demonstrated remarkable intellect and
passion across a range of disciplines,” said Ray Elliott, President
and Chief Executive Officer of Boston Scientific.  “We are
proud to honor his memory by supporting the next generation of
medical leaders.”

Dr. Baim enjoyed a prestigious career that included a position
as Professor of Medicine at Harvard Medical School.  He was a
highly respected physician at Brigham and Women’s Hospital and Beth
Israel Hospital (now Beth Israel Deaconess Medical Center) in
Boston, where he trained many of the interventional cardiology
leaders of today.  Dr. Baim was a prolific author, publishing
nearly 300 scientific papers and editing a leading interventional
cardiology textbook.  He al

‘/>”/>

SOURCE